Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001724287-18-000001
Filing Date
2018-02-22
Accepted
2018-02-22 16:50:03
Documents
1
Effectiveness Date
2018-02-22
Items
Item 06c:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9891
  Complete submission text file 0001724287-18-000001.txt   10977
Mailing Address 1160 HUFFMAN ROAD ATTN: DR. G. SULLIVAN BIRMINGHAM AL 35215
Business Address 1160 HUFFMAN ROAD ATTN: DR. G. SULLIVAN BIRMINGHAM AL 35215 251-401-1187
Bridge Therapeutics, Inc. (Filer) CIK: 0001724287 (see all company filings)

EIN.: 473513057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-306250 | Film No.: 18633226